secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cabaletta Bio, Inc. (CABA)
CIK:        0001759138
Form:       8-K
Filed at:   2024-06-04T23:59:59+00:00
Accession:  0001193125-24-154309
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cabaletta Bio 2024 annual meeting: Bollard and Henriques elected as directors, EY ratified
--------------------------------------------------------------------------------

- Stockholders elected Catherine Bollard and Richard Henriques as Class II directors; Bollard received 26,225,488 for, 12,001,379 withheld; Henriques received 37,806,806 for, 433,474 withheld.
- Ratification of Ernst & Young LLP as independent auditor for FY2024 passed with 41,355,429 for, 38,098 against, 5,728 abstain.
- 46,804,820 shares were outstanding as of the April 4, 2024 record date; no other matters voted on.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759138/000119312524154309/0001193125-24-154309-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759138/000119312524154309/d829742d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-154309

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer